Portable electrolyte-gated organic field-effect transistor platform for enabling ultrasensitive and rapid detection of hepatitis B and C
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.118804 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von María Jesús Ortiz-Aguayo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Bellaterra, 08193, Spain. Hauptthemen laut MEDLINE: Biosensing Techniques, Hepatitis B, Hepatitis C, Hepacivirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: State Agency of Research, Ministerio de Ciencia e Innovación, Generalitat de Catalunya.
Abstract (Originalsprache)
Viral hepatitis, particularly hepatitis B (HB) and hepatitis C (HC), has remained a major global health concern for decades due to its high infectivity and the liver damage it causes, which can lead to severe long-term complications. Thus, the development of diagnostic tools that enable rapid, cost-effective, and user-friendly detection of hepatitis infections is crucial. Here, we report label-free immunosensors for the detection of HB/HC biomarkers (Hepatitis B surface antigen, HBsAg, and Hepatitis C core antigen, HCcAg) using conventional electrolyte-gated organic field effect transistors (EGOFETs) as electrical transducers by modifying the gate contact with suitable antibodies. To enhance portability and enable point-of-care (PoC) operation, the EGOFETs were subsequently integrated into a lateral flow assay architecture (LF-EGOFET), where the antibodies are immobilized within a nitrocellulose membrane in contact with a coplanar gate electrode. The devices were evaluated as PoC diagnostic tests in buffer solutions and diluted artificial saliva, demonstrating high sensitivity, selectivity, and accuracy, with limits of detection (LoD) in the femtomolar range. Notably, the LF-EGOFET platform achieves a LoD over three orders of magnitude lower than those of commercial hepatitis lateral flow assays, while avoiding the use of labels and enabling the identification of discrete concentration ranges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Bellaterra, 08193, Spain.
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Bellaterra, 08193, Spain; Universitat Autònoma de Barcelona, Campus UAB, Bellaterra, Spain.
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Bellaterra, 08193, Spain; CIBER-BBN, Campus UAB, Bellaterra, 08193, Spain. Electronic address: mmas@icmab.es.
Förderung
- State Agency of Research
- Ministerio de Ciencia e Innovación
- Generalitat de Catalunya
- Universitat Autònoma de Barcelona
- European Regional Development Fund
- Government of Catalonia Agency for Administration of University and Research Grants
Zitieren
APA
Ortiz-Aguayo, M. J., López Marzo, A. M., Pan, M., Gutiérrez, D., Martínez-Domingo, C., & Mas-Torrent, M. (2026). Portable electrolyte-gated organic field-effect transistor platform for enabling ultrasensitive and rapid detection of hepatitis B and C. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.118804
Vancouver
Ortiz-Aguayo MJ, López Marzo AM, Pan M, Gutiérrez D, Martínez-Domingo C, Mas-Torrent M. Portable electrolyte-gated organic field-effect transistor platform for enabling ultrasensitive and rapid detection of hepatitis B and C. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.118804
BibTeX
@article{OrtizAguayo2026,
author = {Ortiz-Aguayo, María Jesús and López Marzo, Adaris María and Pan, Mingyue and Gutiérrez, Diego and Martínez-Domingo, Carme and Mas-Torrent, Marta},
title = {Portable electrolyte-gated organic field-effect transistor platform for enabling ultrasensitive and rapid detection of hepatitis B and C},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.118804}
}
EUVIMED